TY - JOUR
AB - Subsequently to the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the western blot data featured in Fig. 3F of the article were strikingly similar to data that had appeared in another article by different authors. Owing to the fact that the contentious data in the above article had already appeared in another article prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors also requested either a corrigendum or a retraction of this paper on account of problems that has been identified with the antibodies used for the western blotting experiments. Upon consulting the authors, they agreed that the article should be retracted. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Letters 16: 179‑188, 2018; DOI: 10.3892/ol.2018.8636]
AD - Department of Otolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
AU - Xu,Jing
AU - He,Jian
AU - Huang,He
AU - Peng,Renjun
AU - Xi,Jian
DA - 2021/08/01
DO - 10.3892/ol.2021.12833
IS - 2
JO - Oncol Lett
KW - glioma
microRNA
pannexin 2
proliferation
apoptosis
PY - 2021
SN - 1792-1074
1792-1082
SP - 572
ST - [Retracted] MicroRNA‑423‑3p promotes glioma growth by targeting PANX2
T2 - Oncology Letters
TI - [Retracted] MicroRNA‑423‑3p promotes glioma growth by targeting PANX2
UR - https://doi.org/10.3892/ol.2021.12833
VL - 22
ER -